Clinical Trial Update: Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating autologous platelet-rich plasma intraovarian infusion for women with poor response to ovulation induction is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Ovarian Failure
• Premature Ovarian Insufficiency
• Reproductive Sterility

Drugs mentioned

• Autologous platelet-rich plasma intraovarian infusion (platelet-rich plasma)

Snippet

Sponsor: Genesis Athens Clinic | Conditions: Poor Response to Ovulation Induction, Infertility, Female | Phase 2, Phase 3 | Status: RECRUITING